首页 | 本学科首页   官方微博 | 高级检索  
     

蛋白酶体抑制剂MG132诱导肿瘤细胞凋亡机制的研究进展
引用本文:饶敏,张淑玲,熊莉娟.蛋白酶体抑制剂MG132诱导肿瘤细胞凋亡机制的研究进展[J].医学分子生物学杂志,2005,2(4):298-301.
作者姓名:饶敏  张淑玲  熊莉娟
作者单位:华中科技大学同济医学院附属协和医院传染科,武汉市,430030
摘    要:MG132(Z-Leu-Leu-Leu-CHO)是一种蛋白酶体抑制剂,能进入细胞中可逆性地抑制蛋白酶体的活性,从而抑制泛素—蛋白酶体通路所介导蛋白质的降解,进而影响细胞周期进程和诱导细胞凋亡。目前,许多文献报道MG132能够诱导多种肿瘤细胞发生凋亡,是一种潜在的抗肿瘤药物。

关 键 词:MG132  蛋白酶体抑制剂  肿瘤
修稿时间:2004年12月13

Advances in the Research of Mechanism of Apoptosis of Tumorous Cells Induceded by Proteasome Inhibitor MG132
Rao Min,ZHANG Shuling,XIONG Lijuan.Advances in the Research of Mechanism of Apoptosis of Tumorous Cells Induceded by Proteasome Inhibitor MG132[J].Journal of Medical Molecular Biology,2005,2(4):298-301.
Authors:Rao Min  ZHANG Shuling  XIONG Lijuan
Affiliation:RAO Min,ZHANG Shuling,XIONG Lijuan Department of Infectious Diseases,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan,430030,China
Abstract:MG132 (Z-Leu-Leu-Leu-CHO) is an inhibitor of proteasome, and it can enter the cell to reversibly inhibit the activation of proteasome, thereby influencing the course of cell cycle and inducing the apoptosis of cells. Currently, it has been reported that MG132 can induce apoptosis of all kinds of tumorous cells and can be used a anti-tumor drug. This article reviews the mechanisms of the apoptosis of the tumorous cells induced by MG132.
Keywords:MG132  proteasome inhibitor  tumor
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号